Genomics & Precision Medicine
Genomics & Precision
Discovery Genomics improves healthcare through technology-enabled molecular science and data analytics. The company utilizes Pharmacogenomics (PGx) and Whole Genome Sequencing (WGS) within an innovative and ethical business structure to provide transformative personalized care. Through Genomics we ensure the development of an ethnically diverse genetic database.
What is Genomics & Precision Medicine
- Discovery Genomics is an advanced molecular science and data analytics company focused on transforming healthcare by developing a platform for personalized and predictive medicine.
- We simplify the sourcing of biospecimens.
- We leverage the informatics available through complex molecular and proteomic analysis that other biorepositories cannot.
- Through our advanced technologies we offer a comprehensive understanding of a person’s complete biological picture, yielding substantial value.
Market Opportunity in Genomics
In 2017, the global genetic market size was valued at $6.2 Billion in the US, and it is expected to grow at a CAGR of 19% over the next decade.
Treatment monitoring, driven heavily by cancer treatment, is valued at $125 Billion.
The global healthcare market is valued at over $8.5 Trillion with a CAGR of 7.3% with health and medical insurance industry comprising over $1 Trillion alone.